Question 1199 — pharmacy and medications

Summary

Mr. Régis Juanico draws the attention of the Minister of Solidarity and Health to the consequences of the change in formula in March 2017 of the drug Levothyrox, which raises many concerns among the 3 million French people to whom this drug is prescribed to correct hypothyroidism. Indeed, many people complain of significant and annoying side effects. According to figures from the National Security Agency of drug, 5,000 reports of unusual effects were recorded at the end of August 2017. Although the active ingredient of the drug, levothyroxine, remained the same, a change in excipient was made in order to make Levothyrox more stable. Among the 3 million patients treated with Levothyrox, some are switching to solutions designed for children or are now purchasing them abroad or on the Internet. Patients denounce the lack of transparency and information regarding this change in formula. The ANSM has also just recognized that they were not sufficiently informed, even going so far as to mention “poor quality information”. Also, he wishes to know the measures envisaged by the Government to resolve this unacceptable situation.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.